Garda Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Garda Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,100	Closed	-$7.03M	–	233
2025 Q2	$7.03M	Sell	13,100 -3,200	-20%	-$1.53M	0.17%	148
2025 Q1	$6.85M	Buy	+16,300	New	+$7.08M	0.17%	182
2024 Q1	–	Sell	-4,300	Closed	-$2.39M	–	483
2023 Q4	$2.39M	Sell	4,300 -1,900	-31%	-$892K	0.21%	116
2023 Q3	$2.71M	Hold	6,200	–	–	0.13%	162
2023 Q2	$3.11M	Buy	6,200 +4,500	+265%	+$2.16M	0.17%	135
2023 Q1	$850K	Buy	+1,700	New	+$814K	0.04%	255

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Garda Capital Partners's IDXX Position: Q2 2025 in Review

Garda Capital Partners sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 1,358 shares — an estimated $649K sold.

Garda Capital Partners first reported a position in IDXX in Q3 2023 and held it in 2 quarters. The position peaked at $812K in Q3 2023. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

Garda Capital Partners reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
Garda Capital Partners sold 1,358 Idexx Laboratories shares in Q2 2025, an estimated $649K.
Garda Capital Partners first reported a position in Idexx Laboratories in Q3 2023 and held it in 2 quarters.
Garda Capital Partners's Idexx Laboratories position peaked at $812K in Q3 2023.
1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Garda Capital Partners's 13F filing for Q2 2025, filed 7 Aug 2025.